Pembrolizumab and Axitinib as Neoadjuvant Therapy for Locally Advanced Non-metastatic Clear Cell Renal Cell Carcinoma
Clinical trial NCT04995016 · UNKNOWN
Trial details
- NCT number
- NCT04995016
- Sponsor
- Tianjin Medical University Second Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-20
- Primary completion
- 2022-08-20
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.